Compare with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs J.B.CHEMICALS - Comparison Results

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES J.B.CHEMICALS ALKEM LABORATORIES/
J.B.CHEMICALS
 
P/E (TTM) x 24.5 31.4 78.0% View Chart
P/BV x 5.9 5.8 101.1% View Chart
Dividend Yield % 0.8 0.2 407.9%  

Financials

 ALKEM LABORATORIES   J.B.CHEMICALS
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-20
J.B.CHEMICALS
Mar-18
ALKEM LABORATORIES/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs2,720363 749.1%   
Low Rs1,660255 651.1%   
Sales per share (Unadj.) Rs697.9169.1 412.6%  
Earnings per share (Unadj.) Rs96.116.6 579.1%  
Cash flow per share (Unadj.) Rs117.323.4 500.8%  
Dividends per share (Unadj.) Rs25.002.00 1,250.0%  
Dividend yield (eoy) %1.10.6 176.4%  
Book value per share (Unadj.) Rs515.2172.5 298.7%  
Shares outstanding (eoy) m119.5783.57 143.1%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x3.11.8 171.8%   
Avg P/E ratio x22.818.6 122.4%  
P/CF ratio (eoy) x18.713.2 141.5%  
Price / Book Value ratio x4.31.8 237.3%  
Dividend payout %26.012.0 215.9%   
Avg Mkt Cap Rs m261,87925,827 1,014.0%   
No. of employees `00014.33.8 379.9%   
Total wages/salary Rs m15,0552,511 599.6%   
Avg. sales/employee Rs Th5,822.63,747.4 155.4%   
Avg. wages/employee Rs Th1,050.5665.7 157.8%   
Avg. net profit/employee Rs Th802.0367.8 218.1%   
INCOME DATA
Net Sales Rs m83,44414,135 590.3%  
Other income Rs m1,042366 284.9%   
Total revenues Rs m84,48614,501 582.6%   
Gross profit Rs m14,7342,178 676.4%  
Depreciation Rs m2,528570 443.7%   
Interest Rs m65135 1,864.2%   
Profit before tax Rs m12,5981,940 649.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,105552 200.0%   
Profit after tax Rs m11,4931,387 828.5%  
Gross profit margin %17.715.4 114.6%  
Effective tax rate %8.828.5 30.8%   
Net profit margin %13.89.8 140.3%  
BALANCE SHEET DATA
Current assets Rs m54,96010,470 524.9%   
Current liabilities Rs m32,4332,749 1,179.8%   
Net working cap to sales %27.054.6 49.4%  
Current ratio x1.73.8 44.5%  
Inventory Days Days8055 144.2%  
Debtors Days Days7278 92.9%  
Net fixed assets Rs m32,7105,811 562.9%   
Share capital Rs m239167 143.1%   
"Free" reserves Rs m61,36814,248 430.7%   
Net worth Rs m61,60714,416 427.4%   
Long term debt Rs m1,5920-   
Total assets Rs m99,43317,649 563.4%  
Interest coverage x20.456.6 36.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.8 104.8%   
Return on assets %12.28.1 151.6%  
Return on equity %18.79.6 193.9%  
Return on capital %21.013.7 153.1%  
Exports to sales %19.10-   
Imports to sales %3.00-   
Exports (fob) Rs m15,917NA-   
Imports (cif) Rs m2,483NA-   
Fx inflow Rs m16,0616,164 260.6%   
Fx outflow Rs m2,4831,334 186.1%   
Net fx Rs m13,5784,829 281.2%   
CASH FLOW
From Operations Rs m5,8511,231 475.5%  
From Investments Rs m-7,414-208 3,562.5%  
From Financial Activity Rs m792-595 -133.0%  
Net Cashflow Rs m-731427 -171.2%  

Share Holding

Indian Promoters % 66.9 55.4 120.8%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 33.1 3.4 976.4%  
FIIs % 0.0 3.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 37.0 -  
Shareholders   68,381 30,437 224.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ORCHID PHARMA  CIPLA  TORRENT PHARMA  VENUS REMEDIES  WYETH  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Plunges 746 Points; Banking & Metal Stocks Bleed(Closing)

Indian share markets witnessed huge selling pressure today and extended losses as the session progressed, dragged down by heavy selling in metal and banking stocks.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (3QFY20); Net Profit Up 34.1% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, J.B.CHEMICALS has posted a net profit of Rs 622 m (up 34.1% YoY). Sales on the other hand came in at Rs 4 bn (up 9.3% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

More Views on News

Most Popular

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

A Rare Chance to Invest in Potential Multibaggers in 2021(Profit Hunter)

Jan 11, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Jan 22, 2021 03:36 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS